Pharmacyclics llc - Company & Market Research Reports

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.


Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market - Product Thumbnail Image

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

  • Report
  • 147 Pages
From
Immune Checkpoint Inhibitors: Clinical Trial Tracker - Product Thumbnail Image

Immune Checkpoint Inhibitors: Clinical Trial Tracker

  • Clinical Trials
From
Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (3rd Edition), 2017-2030

  • Report
  • 347 Pages
From
T-Cell Immunotherapy Market (2nd Edition), 2017-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • Report
  • 654 Pages
From
Drugs and Diagnostics for Hematological Disorders: Global Markets - Product Thumbnail Image

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • Report
  • 504 Pages
From
Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight - Product Thumbnail Image

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

  • Drug Pipelines
  • 573 Pages
From
Hematological Tumor - Pipeline Review, H1 2014 - Product Thumbnail Image

Hematological Tumor - Pipeline Review, H1 2014

  • Report
  • 450 Pages
From
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - Product Thumbnail Image

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020

  • Report
  • 109 Pages
From
Global Non-Hodgkin Lymphoma Therapeutics Market - Growth, Trends and Forecasts 2017 - 2022 - Product Thumbnail Image

Global Non-Hodgkin Lymphoma Therapeutics Market - Growth, Trends and Forecasts 2017 - 2022

  • Report
  • 211 Pages
From
Antibody Drug Conjugates Market (3rd Edition) - Product Thumbnail Image

Antibody Drug Conjugates Market (3rd Edition)

  • Report
  • 357 Pages
From
Cancer Stem Cell Therapies Market, 2017-2030 - Product Thumbnail Image

Cancer Stem Cell Therapies Market, 2017-2030

  • Report
  • 270 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
HDAC Inhibitors Market, 2016 - 2026 - Product Thumbnail Image

HDAC Inhibitors Market, 2016 - 2026

  • Report
  • 233 Pages
From
Follicular Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Follicular Lymphoma - Pipeline Review, H2 2016

  • Report
  • 540 Pages
From
Mantle Cell Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Mantle Cell Lymphoma - Pipeline Review, H2 2016

  • Report
  • 426 Pages
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • Report
  • 1101 Pages
From
Hematological Malignancies Market: By Treatment, & By Region - Forecast 2016-2021 - Product Thumbnail Image

Hematological Malignancies Market: By Treatment, & By Region - Forecast 2016-2021

  • Report
  • 153 Pages
From
Renal Cell Carcinoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Review, H2 2016

  • Report
  • 793 Pages
From
Global Hematological Cancers Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Hematological Cancers Market Analysis 2016 - Forecast to 2022

  • Report
  • 129 Pages
From
Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025

  • Report
  • 401 Pages
From
Loading Indicator
adroll